Published 3 days ago • loading... • Updated 3 days ago

Biotech Stocks To Consider - September 19th

Amgen, Moderna, Gilead Sciences, AbbVie, and Regeneron Pharmaceuticals are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies that develop products or technologies involving biology, such as medicines, vaccin

1 Articles

MarketBeat

Center

Biotech Stocks To Consider - September 19th

3 days ago·Sioux Falls, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated3 days agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States 3 days ago on Saturday, September 19, 2026.

Sources are mostly out of (0)

Biotech Stocks To Consider - September 19th

1 Articles

1 Articles

Biotech Stocks To Consider - September 19th

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

Health: Vitiligo and Alopecia, Experts and Patients 'Are Recognized by Ssn for Access to New Therapies'

Medications: Vitiligo and Alopecia, Cordella (AbbVie) Are Committed to Improving Standards of Care Also

Serbian Biotech Startup Takes Its Journey from Belgrade to Cambridge with Documentary on Longevity Science

New mRNA Flu Vaccine Approved for Adults 50 and Older Ahead of Flu Season

Chinese Biopharma Stocks Rally as U.S. Signals Openness to Drug Licensing

ADARx Pharmaceuticals targets $1.74 billion valuation in US IPO

Similar News Topics

Similar News Topics

More stories like this

Health: Vitiligo and Alopecia, Experts and Patients 'Are Recognized by Ssn for Access to New Therapies'

Medications: Vitiligo and Alopecia, Cordella (AbbVie) Are Committed to Improving Standards of Care Also

Serbian Biotech Startup Takes Its Journey from Belgrade to Cambridge with Documentary on Longevity Science

New mRNA Flu Vaccine Approved for Adults 50 and Older Ahead of Flu Season

Chinese Biopharma Stocks Rally as U.S. Signals Openness to Drug Licensing

ADARx Pharmaceuticals targets $1.74 billion valuation in US IPO

Biotech Stocks To Consider - September 19th

1 Articles

1 Articles

Biotech Stocks To Consider - September 19th

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

Health: Vitiligo and Alopecia, Experts and Patients 'Are Recognized by Ssn for Access to New Therapies'

Medications: Vitiligo and Alopecia, Cordella (AbbVie) Are Committed to Improving Standards of Care Also

Serbian Biotech Startup Takes Its Journey from Belgrade to Cambridge with Documentary on Longevity Science

New mRNA Flu Vaccine Approved for Adults 50 and Older Ahead of Flu Season

Chinese Biopharma Stocks Rally as U.S. Signals Openness to Drug Licensing

ADARx Pharmaceuticals targets $1.74 billion valuation in US IPO

Similar News Topics

Similar News Topics

More stories like this

Health: Vitiligo and Alopecia, Experts and Patients 'Are Recognized by Ssn for Access to New Therapies'

Medications: Vitiligo and Alopecia, Cordella (AbbVie) Are Committed to Improving Standards of Care Also

Serbian Biotech Startup Takes Its Journey from Belgrade to Cambridge with Documentary on Longevity Science

New mRNA Flu Vaccine Approved for Adults 50 and Older Ahead of Flu Season

Chinese Biopharma Stocks Rally as U.S. Signals Openness to Drug Licensing

ADARx Pharmaceuticals targets $1.74 billion valuation in US IPO

Bias Distribution

Factuality